| Dr Mohammad M Zarrinnegar, DDS | |
|
860 E Remington Dr, #j, Sunnyvale, CA 94087-2995 | |
| (408) 736-6266 | |
| (408) 738-1557 |
| Full Name | Dr Mohammad M Zarrinnegar |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 860 E Remington Dr, Sunnyvale, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164677605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 45634 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohammad M Zarrinnegar, DDS 860 E Remington Dr, #j, Sunnyvale, CA 94087-2995 Ph: (408) 736-6266 | Dr Mohammad M Zarrinnegar, DDS 860 E Remington Dr, #j, Sunnyvale, CA 94087-2995 Ph: (408) 736-6266 |
News Archive
Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia") today announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the District of Maryland on behalf of purchasers of the common stock of Coventry Health Care, Inc. ("Coventry" or the "Company") between February 9, 2007 and October 22, 2008, inclusive (the "Class Period"), seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act").
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.
Three new studies provide converging evidence pointing to a new therapeutic target in Alzheimer's Disease(AD). These studies, from independent academic centers in the U.S., England, and China, point to excess levels of a protein called TNF as a key factor in AD. TNF is an immune signaling protein that regulates both inflammation and neuronal communication in the brain.
A new study has found that one in three early-stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of recurrence. About one in four experienced distress when receiving their test results.
› Verified 6 days ago
Dr. Sheetal S Gokhale, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 697 E Remington Dr Ste B, Sunnyvale, CA 94087 Phone: 408-245-0600 Fax: 408-245-0047 | |
Dr. Wade W Lee, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 685 E Remington Dr Ste B, Sunnyvale, CA 94087 Phone: 408-737-9633 | |
Grace Hsiao-fei Chyuwei, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1210 E Arques Ave, Suite 212, Sunnyvale, CA 94085 Phone: 408-749-9018 Fax: 408-749-9048 | |
Dr. Tetyana Iosifovna Varnava, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 660 S Bernardo Ave Ste 3, Sunnyvale, CA 94087 Phone: 408-523-1400 Fax: 408-523-1444 | |
Dr. Rob M Cisneros, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 990 W Fremont Ave Ste A, Sunnyvale, CA 94087 Phone: 408-738-0656 | |
Dr. Varsha Y Patel, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 990 W Fremont Ave, Suite C, Sunnyvale, CA 94087 Phone: 408-720-8555 | |
Dr. Kalaivani K Kulandaivelu, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 990 W Fremont Ave, Suite Y, Sunnyvale, CA 94087 Phone: 408-735-7161 Fax: 408-735-7173 |